Litcius/Paper detail

VP2-2021: Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small cell lung cancer (Nsq-NSCLC) with high PD-L1 expression using real-world data

Solange Peters, Urania Dafni, M. Pérol, Enriqueta Felip, Letizia Polito, Navdeep Pal, T.G.N. Ton, David M. Merritt, S. Morris, R. Stahel

2021Annals of Oncology16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineHazard ratioOncologyChemotherapyLung cancerPD-L1CohortImmunotherapyRetrospective cohort studyCancerConfidence intervalCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
VP2-2021: Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small cell lung cancer (Nsq-NSCLC) with high PD-L1 expression using real-world data | Litcius